Treatment perspectives and challenges in antifungal therapy for mucormycosis in patients with COVID-19. Research, Society and Development, [S. l.], v. 14, n. 3, p. e5414348442, 2025. DOI: 10.33448/rsd-v14i3.48442. Disponível em: https://www.rsdjournal.org/rsd/article/view/48442. Acesso em: 5 dec. 2025.